IU Research created and launched a webpage to share official federal agency communications and relevant updates regarding changes to agency operations that may affect research at IU. New communications will be added as they are received. Please be sure to check back regularly and note the date of each posted update to ensure you’re reading the most recent.
The IU Simon Comprehensive Cancer Center was selected as one of five cancer centers nationwide to serve as a site for the Future Deaf Scientists Program. The cancer center will partner with the Indiana School for the Deaf to place five high school students in this summer program beginning in July. Participants will shadow researchers in laboratory and clinical spaces and participate in fireside chats with Deaf scientists and clinicians from across the country. As part of the IU Simon Comprehensive Cancer Center summer programs, students will receive a stipend.
The Future Deaf Scientists Program and curriculum was developed by the University of Rochester James P. Wilmot Cancer Institute. In addition to IU, the Wilmot Cancer Institute is expanding the program to the UK Markey Cancer Center, Stanford Cancer Institute and Yale Cancer Center.
The Biospecimen Collection and Banking Core (BC²) hosted a two-day live, interactive open house and seminar in collaboration with Manifold, showcasing a powerful new platform designed to enhance data access and usability. In addition to the beta testers who participated ahead of the open house, more than 30 researchers secured credentials on the spot, gaining immediate access to the system and building their own research cohorts in real time—bringing the total number of onboarded users to more than 70.
Attendees explored BC²’s vast collection of more than 27,000 donors, leveraged self-service tools to refine their data searches, and combined multiple data types to enrich their analyses. The interactive format allowed participants to experience firsthand how seamlessly they could access datasets and get answers to key research questions at their fingertips with the new platform.
If you’re interested in getting access to the new system, reach out to Jill Henry at jihenry@iu.edu for more details.
The National Comprehensive Cancer Network (NCCN) published a new resource to inform people about the latest recommendations around hereditary and familial cancer risk. This is the first supportive care book on this topic published specifically for patients and caregivers from NCCN. It's based on the evidence-based, expert consensus-driven content from the recently-expanded clinical guidelines on genetic/familial high-risk assessment for breast, ovarian, pancreatic and prostate cancers. Nawal Kassem, MD, is among the experts who helped set the recommendations for the clinical guidelines used to develop this resource.
Empowering Black Health: A Celebration of Heritage & Wellness will be 6-7:30 p.m. Friday, Feb. 28, at the Madam Walker Legacy Center, 617 Indiana Ave., Indianapolis. This year’s focus on advocacy, prevention/screening, and self-care will spark meaningful conversations and celebrate health equity. Space is limited and advance registration is required. Register now.
George E. Sandusky, DVM, PhD, will present “The History of Chemotherapy” at the John Shaw Billings History of Medicine Lecture at noon on Feb. 18. Register to attend on Zoom or in-person at the Daly Student Center.
Kathy Miller, MD (EDT), discusses the top fall 2024 breast cancer research in an episode of The Breastcancer.org Podcast.
Lisa Landrum, MD, PhD (EDT), is profiled in this IU School of Medicine Women in Medicine blog post, highlighting her achievement as the first woman to lead OB-GYN department at IU.
Katy Ellis Hilts, PhD (CPC), has joined the editorial board of the Journal of Public Health Management and Practice. Read more.
Shelley Johns, PsyD (CPC), recently published findings on the fear of breast cancer recurrence. Read the recent news release.
Peter Gunderman, MD
Associate member, Cancer Prevention and Control
John Allen, PharmD
Full member, Cancer Prevention and Control
